Gene Regulation, Stem Cells and Cancer Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), 08003 Barcelona, Spain.
Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Cancer Cell. 2016 Nov 14;30(5):694-707. doi: 10.1016/j.ccell.2016.10.004. Epub 2016 Oct 27.
RNA binding proteins (RBPs) modulate cancer progression through poorly understood mechanisms. Here we show that the RBP UNR/CSDE1 is overexpressed in melanoma tumors and promotes invasion and metastasis. iCLIP sequencing, RNA sequencing, and ribosome profiling combined with in silico studies unveiled sets of pro-metastatic factors coordinately regulated by UNR as part of RNA regulons. In addition to RNA steady-state levels, UNR was found to control many of its targets at the level of translation elongation/termination. Key pro-oncogenic targets of UNR included VIM and RAC1, as validated by loss- and gain-of-function studies. Our results identify UNR as an oncogenic modulator of melanoma progression, unravel the underlying molecular mechanisms, and identify potential targets for this therapeutically challenging malignancy.
RNA 结合蛋白(RBPs)通过尚未完全了解的机制调节癌症的进展。在这里,我们发现 RBP UNR/CSDE1 在黑色素瘤肿瘤中过度表达,并促进侵袭和转移。iCLIP 测序、RNA 测序和核糖体分析与计算机研究相结合,揭示了一组由 UNR 协调调控的促转移因子,这些因子是 RNA 调控因子的一部分。除了 RNA 的稳态水平外,研究还发现 UNR 还控制着许多其靶基因在翻译延伸/终止水平上的表达。UNR 的关键原癌基因靶标包括 VIM 和 RAC1,这一点通过功能丧失和功能获得研究得到了验证。我们的研究结果确定 UNR 是黑色素瘤进展的致癌调节剂,揭示了潜在的分子机制,并为这种具有挑战性的治疗性恶性肿瘤确定了潜在的治疗靶点。